SG Americas Cuts Teleflex Holdings by Over 50% Amid Market Shifts

SG Americas Securities LLC has significantly reduced its stake in Teleflex Incorporated, decreasing its holdings by 50.6% during the third quarter of 2023. This information was revealed in the firm’s latest 13F filing with the U.S. Securities and Exchange Commission (SEC). After selling 4,994 shares, SG Americas now owns 4,867 shares of the medical technology company, valued at approximately $596,000.

The reduction in SG Americas’ investment is part of a broader trend among institutional investors regarding Teleflex. Several hedge funds have made moves in the company’s stock during the same period. For example, Russell Investments Group Ltd. increased its stake by 23.6% in the second quarter, acquiring an additional 15,935 shares to bring its total to 83,388 shares, worth around $9,870,000. Similarly, Creative Planning boosted its holdings by a remarkable 76.5%, now owning 10,338 shares valued at approximately $1,224,000.

CWM LLC made a notable increase of 160.8% to its stake, now holding 11,904 shares worth $1,409,000. Additionally, the Teacher Retirement System of Texas raised its holdings by 31.5%, owning 11,819 shares valued at around $1,399,000. Collectively, institutional investors and hedge funds own 95.62% of Teleflex’s stock.

Market Performance and Analyst Ratings

As of the latest trading session, Teleflex shares opened at $105.09. The company’s stock has seen a range between a 12-month low of $100.18 and a high of $185.94. Teleflex currently holds a market capitalization of $4.64 billion and has a debt-to-equity ratio of 0.67. Its price-to-earnings (PE) ratio stands at -14.30, indicating a challenging earnings environment, with a price-to-earnings-growth (PEG) ratio of 1.34.

Teleflex recently announced a quarterly dividend of $0.34 per share, which was paid on December 15, 2023. The dividend’s ex-dividend date was November 14, 2023. This results in an annualized dividend of $1.36 and a yield of 1.3%, though the company’s dividend payout ratio (DPR) is currently recorded at -18.50%.

Analysts’ views on Teleflex’s stock have varied. Weiss Ratings reaffirmed a “sell (d)” rating, while Wells Fargo & Company upgraded their target price from $114.00 to $139.00 and maintained an “equal weight” rating. Needham & Company LLC reiterated a “hold” rating, while Zacks Research adjusted their rating from “strong-buy” to “hold.” Currently, one analyst rates the stock as a Buy, nine as Hold, and two as Sell. The consensus rating stands at “Reduce” with a target price of $142.43, according to MarketBeat data.

About Teleflex Incorporated

Teleflex Incorporated is a global provider of medical technologies with a focus on critical care and surgical solutions. Based in Wayne, Pennsylvania, the company designs, manufactures, and distributes products used by healthcare professionals across various settings, including hospitals and ambulatory care. Teleflex aims to enhance patient outcomes through its diverse offerings, which include segments such as Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, and Vascular solutions.

As Teleflex navigates the complexities of the medical technology market, its recent share price movements and institutional investments highlight the evolving landscape of investor sentiment in the sector.